Lagardère S.A. : Good timing to go long again
Entry price | Target | Stop-loss | Potential |
---|
€23.5 |
€25.5 |
€21.96 |
+8.53% |
---|
Pursuant to the correction that has taken place in recent weeks with respect to the shares in Lagardère, further downside risk now appears limited by close and important technical support levels at 21.96 EUR.
Summary● The company has solid fundamentals for a short-term investment strategy.
Strengths● The share is getting closer to its long-term support in weekly data, at EUR 22.84, which offers good timing for buyers.
● The company shows low valuation levels, with an enterprise value at 0.61 times its sales.
● This company will be of major interest to investors in search of a high dividend stock.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
● The stock is in a well-established, long-term rising trend above the technical support level at 22.84 EUR
Weaknesses● According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The group usually releases earnings worse than estimated.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.